As of 2025, Zepbound is FDAapproved for chronic weight management in adults with obesity or overweight plus a weightrelated condition, and also for moderatetosevere obstructive sleep apnea in adults with obesityalways paired with lifestyle changes
Compounded semaglutide products are not required to go through the same type of testing, so they are not evaluated for safety, effectiveness, or quality, in the same ways that FDA-approved drugs like Ozempic are
Although scientists are still trying to figure out the neurobiological reasons for depression, several working theories are driving research and treatment development
Weight loss of 2 to 5 pounds during this phase is typical
GHK-Cu is not primarily a performance or injury-repair peptide
They have become super popular because they are great at helping manage weight, but thats not all